Biocon launches denosumab biosimilars Bosaya and Aukelso in US market
Interchangeable biosimilars to Prolia and Xgeva target osteoporosis and cancer-related bone complications in a $5 billion U.S. market
Interchangeable biosimilars to Prolia and Xgeva target osteoporosis and cancer-related bone complications in a $5 billion U.S. market
The center combines rigorous scientific instruction with practical, hands-on training, equipping providers with the clinical, consultative, and business skills needed to deliver safe, effective, and patient-centered care
Chronic GVHD is a serious and potentially life-threatening condition, imposing profound physical and emotional burdens on a substantial proportion of patients following allogeneic stem cell transplantation
MoU to deploy Qure.ai’s chest X-ray solution across 20 government facilities aims to improve early detection in urban and rural populations
Veteran HR leader comes with over two decades of experience to spearhead talent strategy, leadership development, and culture transformation
With more than two decades of experience, he brings deep expertise in sales, marketing, business transformation, and strategic leadership
Participants also experienced a VR-enabled learning environment designed to support clinical skill development in controlled, repeatable, and risk-free settings
Researchers say simple blood-test and echocardiography pathway could reshape diabetes-related cardiovascular care
Move aligns global biologics identity under the Biocon Biologics brand
Collaboration to study integration of AI-enabled VR solutions into medical and nursing curricula
Subscribe To Our Newsletter & Stay Updated